Cardiol Therapeutics Inc Class A - Asset Resilience Ratio

Latest as of September 2025: 89.76%

Cardiol Therapeutics Inc Class A (CRDL) has an Asset Resilience Ratio of 89.76% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Cardiol Therapeutics Inc Class A for a breakdown of total debt and financial obligations.

Liquid Assets

CA$11.62 Million

≈ $8.41 Million USD Cash + Short-term Investments

Total Assets

CA$12.95 Million

≈ $9.37 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how Cardiol Therapeutics Inc Class A's Asset Resilience Ratio has changed over time. See CRDL net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Cardiol Therapeutics Inc Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Cardiol Therapeutics Inc Class A market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$11.62 Million	89.76%
Short-term Investments	CA$0.00	0%
Total Liquid Assets	CA$11.62 Million	89.76%

Asset Resilience Insights

Very High Liquidity: Cardiol Therapeutics Inc Class A maintains exceptional liquid asset reserves at 89.76% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Cardiol Therapeutics Inc Class A Industry Peers by Asset Resilience Ratio

Compare Cardiol Therapeutics Inc Class A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	1.96%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	8.47%

Annual Asset Resilience Ratio for Cardiol Therapeutics Inc Class A (2017–2024)

The table below shows the annual Asset Resilience Ratio data for Cardiol Therapeutics Inc Class A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	95.97%	CA$30.58 Million ≈ $22.12 Million	CA$31.86 Million ≈ $23.05 Million	+0.62pp
2023-12-31	95.35%	CA$34.99 Million ≈ $25.31 Million	CA$36.70 Million ≈ $26.55 Million	-0.63pp
2022-12-31	95.97%	CA$59.53 Million ≈ $43.06 Million	CA$62.03 Million ≈ $44.87 Million	+0.43pp
2021-12-31	95.54%	CA$83.96 Million ≈ $60.74 Million	CA$87.88 Million ≈ $63.57 Million	+6.91pp
2020-12-31	88.63%	CA$14.09 Million ≈ $10.19 Million	CA$15.89 Million ≈ $11.50 Million	+43.37pp
2019-12-31	45.27%	CA$7.02 Million ≈ $5.08 Million	CA$15.50 Million ≈ $11.21 Million	-22.52pp
2018-12-31	67.78%	CA$16.73 Million ≈ $12.10 Million	CA$24.68 Million ≈ $17.86 Million	-5.39pp
2017-12-31	73.17%	CA$2.36 Million ≈ $1.70 Million	CA$3.22 Million ≈ $2.33 Million	--

pp = percentage points

About Cardiol Therapeutics Inc Class A

TO:CRDL Canada Drug Manufacturers - Specialty & Generic

Market Cap

$148.65 Million

CA$205.49 Million CAD

Market Cap Rank

#17675 Global

#569 in Canada

Share Price

CA$1.84

Change (1 day)

-1.08%

52-Week Range

CA$1.28 - CA$2.23

All Time High

CA$8.13